Skip to main content
Veterinary Medicines

Neofort 700 mg/g Proszek do sporządzania roztworu doustnego

Authorised
  • NEOMYCIN SULFATE

Product identification

Medicine name:
Neofort 700 mg/g Proszek do sporządzania roztworu doustnego
Active substance:
  • NEOMYCIN SULFATE
Target species:
  • Turkey
  • Pig
  • Sheep
  • Cattle
  • Chicken (hen)
  • Goat
Route of administration:
  • In drinking water/milk use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    700.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Turkey
      • Meat and offal
        7
        day
    • Pig
      • Meat and offal
        14
        day
    • Sheep
      • Meat and offal
        14
        day
    • Cattle
      • Meat and offal
        14
        day
    • Chicken (hen)
      • Meat and offal
        7
        day
    • Goat
      • Meat and offal
        14
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA01
Authorisation status:
  • Valid
Authorised in:
  • Poland
Available in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Biofaktor Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biofaktor Sp. z o.o.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0425
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."